← FDA Drug Approvals (Drugs@FDA)

CABERGOLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IVAX SUB TEVA PHARMS · Approved 2007-03-07

Drug application

FDA Application #

ANDA077750

Application type

Abbreviated New Drug Application (Generic)

Brand name

CABERGOLINE

Generic name

CABERGOLINE

Active ingredients

CABERGOLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

IVAX SUB TEVA PHARMS

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2007-03-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown